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Objective: American-style football (ASF) has gained attention because of possible links between repetitive head injury
and neurodegenerative diseases. Although postmortem pathologic changes consistent with chronic traumatic encepha-
lopathy (CTE) have been reported in ASF players, there are currently no established premortem diagnostic criteria for
CTE. Nevertheless, presented with symptoms of cognitive impairment, clinicians treating former players may be
inclined to suggest CTE without a thorough exploration of comorbid factors that demonstrate similar clinical
phenotypes to putative CTE.
Methods: A survey of 3,913 former ASF players aged 24 to 89 was conducted for those who responded by March 2019.
Results: Despite being a postmortem diagnosis, 108 players (2.8%) self-reported clinician-diagnosed CTE. The percent-
age of players under age 60 years reporting a CTE diagnosis was 2.3% versus 3.7% in participants age 60 or older. Com-
orbidities in participants self-reporting CTE were significantly more common, including sleep apnea,
hypercholesterolemia, obesity, indicators of past or current depression, hypertension, prescription pain medication use,
heart conditions, and low testosterone when compared to non-CTE respondents. Patterns of reporting for obesity,
hypertension, heart conditions, or hypercholesterolemia differed between older and younger participants. Cognitive
impairment symptoms were significantly higher in participants self-reporting CTE.
Interpretation: Some former professional football players have been clinically diagnosed with CTE, a postmortem con-
dition. Comorbidities that can affect cognition were associated with CTE diagnoses in both older and younger players.
Although underlying neuropathology cannot be ruled out, treatable conditions should be explored in former athletes
demonstrating CTE-linked clinical phenotypes or symptoms as a means of improving cognitive health in these patients.
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Scientific and news media have paid considerable attentionto the idea that cognitive impairment in American-style
football (ASF) players may be a consequence of repeated head
trauma.1 First reported by Martland in 1928 as punch drunk
syndrome,2 chronic traumatic encephalopathy (CTE) is a
neurodegenerative disease pathologically defined at autopsy
by deposition of phosphorylated tau (P-tau) in neurons, astro-
cytes, and cell processes around perivascular structures at the
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depths of the cortical sulci.3 Recent work has noted postmor-
tem pathologic changes consistent with CTE in 177 of
202 ASF players.4,5 The 177 affected ASF players had a
median age at death of 67 years and retrospective analysis
found that the majority had shown cognitive, emotional, and
behavioral symptoms for over a decade prior to autopsy.
However, the relationship between CTE pathology
and clinical phenotypes among former ASF athletes
remain incompletely understood.6,7 A series of clinical
diagnostic criteria have been proposed that include behav-
ioral, cognitive, and motoric features.8–10 Yet, the agree-
ment between the clinical features of these proposed
criteria is modest.11 in vivo flortaucipir positron emission
tomography (PET) imaging has revealed higher tracer
retention in former professional ASF players with cogni-
tive and neuropsychiatric symptoms in brain regions
affected by CTE.12 Nonetheless, there was no association
between tau deposition as registered on imaging and
scores on cognitive and neuropsychiatric tests.
The specificity13 and progressive nature of CTE5 have
not been fully elucidated, and some evidence suggests that
CTE may not be solely unique to repeated head trauma.13,14
Additionally, in former ASF players with cognitive symp-
toms, CTE pathology—even when present—might not be
the sole contributor of cognitive decline.6,15 Thus, while
National Institute of Neurological Disorders and Stroke
(NINDS) pathologic criteria exist,3 continued refinement of
these criteria is needed to better differentiate CTE from other
neurodegenerative diseases, such as aging-related tau
astrogliopathy. The limitations of in vivo diagnostic tests,
absence of clear links between neuropathology, and cognitive
symptoms,6,7 the multifactorial nature of cognitive decline
in older age groups, and the impact of possible com-
orbidities on clinical presentations often impede the identi-
fication of definite etiological factors in CTE. As a result,
the clinical criteria for antemortem CTE or traumatic
encephalopathy syndrome remain proposed16,17 but not
yet established.6,7,11
While clinical criteria for CTE or traumatic encepha-
lopathy syndrome remain in debate, few studies have
addressed the potential comorbid factors that can impact
cognitive function.11 In the Football Players Health Study
(FPHS), we investigated the self-reporting of CTE diagnoses




Starting in 2014, the FPHS18 recruited former football
players who had received compensation from any National
Football League (NFL) team starting in 1960, when the
league transitioned from soft leather to hard plastic hel-
mets.19 We explicitly considered active players ineligible.
We obtained email and residential information for 16,089
eligible former players from the NFL Players Association.
Of these, return-to-sender address errors or unopened
email messages were documented for 1,675 unique former
players. Of the remaining 14,414 former players, 3,913
(27.1%) had enrolled as of March 2019. This study was
approved by the Institutional Review Board of the Beth
Israel Deaconess Medical Center and the Harvard
T.H. Chan School of Public Health, and participants pro-
vided informed consent prior to participation.
Outcome and Other Data
Participants completed either a paper or online question-
naire about demographics, football careers, and health con-
ditions. Body mass index (BMI) was calculated from self-
reported weight (lbs) and height (inches) as (lbs*0.45/
(inches*0.025).2 Players on the offensive or defensive line
were categorized as linemen, and all others were categorized
as non-linemen. Participants were asked to select categories
that described their racial identity: black/African American;
white; American Indian/Alaskan Native; Native Hawaiian/
Pacific Islander; Asian and other. Black was defined as
players who self-identified as black or African American.
Former players who self-selected “black” in addition to
another race were categorized as black, based on lived experi-
ence studies that have shown that perceivers strongly tend to
characterize multiracial individuals as belonging to a minor-
ity status.20 White was defined as players who self-identified
only as white. Participants who declined to answer this ques-
tion were categorized as “missing.” All remaining partici-
pants were categorized as “other.” Number of seasons of
professional NFL play was divided into 1 to 4 seasons, 5 to
9 seasons, and 10+ seasons.
We considered several different health conditions as
reported by the former players. Heart attack, sleep apnea,
stroke, dementia, and CTE was based on a yes/no
response to the question for the given condition phrased
as “Has a Health care provider ever told you that you
have had any of the following diagnoses or health out-
comes?” followed by options that included: heart attack;
sleep apnea; stroke; dementia (Alzheimer’s disease); and
CTE. Further definitions for these conditions were not
provided. We considered a yes response to the question
phrased as “Has a medical provider ever recommended
or prescribed medication for any of the following condi-
tions?” for “high blood pressure,” “diabetes or high blood
sugar,” “high cholesterol,” “low testosterone,” “erectile
dysfunction (ED),” and “pain” as an indicator of hyper-
tension, diabetes, hypercholesterolemia, low testosterone,
erectile dysfunction, and chronic pain, respectively. We
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defined having a heart condition as reporting any of the
following: (1) diagnosis of “heart attack,” (2) medication
recommendations or prescriptions for “heart failure” or
“heart rhythm problems (atrial fibrillation, supraventricu-
lar tachycardia [SVT], or other),” or (3) positive
responses to the question “Since leaving active profes-
sional play have you had any of the following surgical
procedures?” specifically for heart bypass, angioplasty, or
stent replacement?
We defined indicators of past or current depression
as having (1) a current prescription or prescription rec-
ommendation for an antidepressant, or (2) a score >3
on the depression-related Patient Health Questionnaire
(PHQ-4).21 The Quality of Life in Neurological Disor-
ders (NQOL) instrument for Applied Cognition-General
Concerns22 was used to measure cognitive symptoms. The
frequencies of 8 symptoms over the previous week were
summed and T-scored according to a standardized US
sample. Participants who scored 2 or more SDs below the
mean were considered to have cognitive impairment.
Statistical Analysis
We used chi-square tests to determine statistically signifi-
cant differences in health conditions between former
players who did and did not report diagnoses of CTE. Sta-
tistical significance was considered at a 95% level of confi-
dence and evaluated using R Statistical Software.23
Results
The mean age was 52.4 (SD = 14.3; range: 24–89) in the
3,913 former ASF players who responded to the question-
naire. The frequency of self-reported CTE diagnoses was
108 (2.8%) among all players, and 59 (2.3%) in players
under age 60 versus 49 (3.7%) in players age 60 or older
(Table 1). Black former players reported a higher percent-
age of CTE than white or other categories. In both age
groups, the percentage of linemen self-reporting CTE was
higher than in non-linemen. The percentage of CTE
reporting did not increase monotonically with more
playing seasons: CTE reporting was highest in the 5 to
9 season category, but not with 10+ seasons (see Table 1).
TABLE 1. Demographic and Football-related Characteristics in Former ASF Players by Age and Self-reported
CTE Status (N = 3,913)













Characteristic N (%) N (%) N (%) N (%) N (%) N (%)
Age
<60 2,518 (97.7) 59 (2.3) - - - -
60+ 1,287 (96.3) 49 (3.7) - - - -
Racea
Black 1,413 (96.6) 50 (3.4) 1,116 (97.1) 33 (2.9) 297 (94.6) 17 (5.4)
White 2,234 (97.6) 56 (2.4) 1,299 (98.1) 25 (1.9) 935 (96.8) 31 (3.2)
Other 110 (98.2) 2 (1.8) 83 (98.8) 1 (2.9) 27 (96.4) 1 (3.6)
Position
Non-linemen 2,492 (97.4) 66 (2.6) 1,640 (98.0) 34 (2.0) 852 (96.4) 32 (3.6)
Linemen 1,313 (96.9) 42 (3.1) 878 (97.2) 25 (2.8) 435 (96.2) 17 (3.8)
Seasons played in NFLb
1–4 Seasons 1,258 (97.7) 29 (2.3) 914 (97.9) 20 (2.1) 344 (97.5) 9 (2.5)
5–9 Seasons 1,633 (96.8) 54 (3.2) 1047 (97.6) 26 (2.4) 586 (95.4) 28 (4.6)
10+ Seasons 914 (97.3) 24 (2.7) 557 (97.7) 13 (2.3) 357 (96.7) 12 (3.3)
aRacial identity was not reported for 48 players, none of whom reported CTE. bYears played for one player could not be ascertained.
ASF = American-style football; CTE = chronic traumatic encephalopathy; NFL = National Football League.
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Men of all ages self-reporting a CTE diagnosis were
significantly more likely to also report obesity, sleep apnea,
indicators of past or current depression, stroke, hyperten-
sion, use of prescription pain medication, low testosterone,
hypercholesterolemia, dementia, and cognitive impairment
(Table 2). Obesity was associated with CTE reporting in
older but not younger participants, whereas hypertension,
any heart condition, and hypercholesterolemia were signifi-
cantly more common in younger but not older former
players (see Table 2).
Discussion
We found that a number of former ASF players reported
clinician-diagnosed CTE. Participants reporting CTE also fre-
quently disclosed other comorbidities with well-established
independent adverse cognitive effects. There is currently no
validated way to clinically diagnosis CTE,6 and concerns have
been raised regarding the specificity of many symptoms
attributed to CTE.13 Thus, it is disconcerting that a percent-
age of former players report being told they have a condition
that can only be diagnosed postmortem.
Participants may have reported CTE because clinicians
told them they have CTE. This is concerning in the absence
of validated diagnostic methods, and may imply that expo-
sure to professional football is driving the suggestion of
CTE rather than differential diagnoses based on systematic
evaluation. Previous research has linked elements of profes-
sional ASF exposure to mood disorders,24 aggression,25 and
hormonal and sexual dysfunction.26,27 Recently, years of
professional play, concussion history, and position were sig-
nificantly associated with neuropsychiatric symptoms in the
largest study of living ASF football players to date.28 These
results align with prior work in nonprofessional football
cohorts suggesting a link between cumulative head impacts
and neurobehavioral symptoms.29 Using either exposure to
TABLE 2. Current Health Conditions and Neurological Quality of Life Impairment Status in Former ASF Players
by Age and selS-reported CTE Status (N = 3,913)













Characteristic N (%) N (%) N (%) N (%) N (%) N (%)
Obese (>30.0 kg/m2)a 1,976 (51.9) 71 (65.7)** 1,373 (54.5) 38 (64.4) 603 (46.9) 33 (67.3)**
Sleep apnea 817 (21.5) 52 (48.1)*** 468 (18.6) 25 (42.4)*** 349 (27.1) 27 (55.1)***
Indicators of past or current depression 631 (16.6) 73 (67.6)*** 426 (16.9) 42 (71.2)*** 205 (15.9) 31 (63.3)***
Diabetes 336 (9.1) 14 (14.0) 156 (6.3) 4 (7.4) 180 (14.7) 10 (21.7)
Hypertensionb 1,414 (37.5) 54 (50.5)** 685 (27.4) 24 (41.4)* 729 (57.4) 30 (61.2)
Low testosteronec 654 (17.7) 40 (37.4)*** 373 (15.1) 25 (43.1)*** 281 (22.9) 15 (30.6)
Stroke 101 (2.7) 7 (6.5)* 34 (1.4) 2 (3.4) 67 (5.2) 5 (10.2)
Rx pain medication 1,016 (26.7) 62 (57.4)*** 591 (23.5) 35 (59.3)*** 425 (33.0) 27 (55.1)***
Heart conditiond 696 (18.3) 26 (24.1) 233 (9.3) 11 (18.6)* 463 (36.0) 15 (30.6)
High cholesterole 1,284 (34.3) 50 (48.1)** 598 (24.1) 26 (45.6)*** 686 (54.7) 24 (51.1)
Dementia 97 (2.5) 41 (38.0)*** 30 (1.2) 20 (33.9)*** 67 (5.2) 21 (42.9)***
Cognitive impairmentf 434 (11.4) 60 (56.1)*** 311 (12.4) 34 (57.6)*** 123 (9.6) 26 (54.2)***
aTwenty-eight players were missing body mass index data.
bThirty-five players were missing hypertension data.
cNinety-two players were missing low testosterone data.
dHeart condition includes self-reported heart rhythm issues, myocardial infarction, heart failure, or cardiac surgery.
eSeventy-four players were missing cholesterol data.
fTen players were missing neurological quality of life scores.
*p < 0.05;
**p < 0.01,
***p < 0.001 on chi-square test.
ASF = American-style football; CTE = chronic traumatic encephalopathy.
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football as a proxy for repetitive head injury, or using mood
and behavioral changes as a phenotypic marker of brain
degeneration, clinicians familiar with this literature may be
inclined to suggest CTE before considering other contribu-
tors to cognitive symptoms.
Alternatively, former players may infer the presence
of CTE when other explanations for cognitive impairment
are not provided.30 The common reporting of com-
orbidities that can affect cognition among players disclos-
ing a CTE diagnosis raises the concern that treatable
conditions are going untreated or undertreated. For exam-
ple, players younger than age 60 reporting CTE also
reported significantly more sleep apnea, indicators of past
or current depression, hypertension, chronic pain, low tes-
tosterone, heart conditions, and hypercholesterolemia.
Participants reporting prior depression or current symp-
toms of depression were more likely to report CTE diag-
noses. We note that our definition combines medical
history of diagnosis or treatment for depression and cur-
rent symptoms. Therefore, the percentage of those meet-
ing our criteria is likely greater than that of either of those
two considered alone. Given that there are no established
premortem clinical criteria for CTE,11 it is possible that
the self-reported diagnosis of CTE was a misinterpretation
by former players of what they had been told by their cli-
nicians, or assumed even when CTE was not explicitly
mentioned. It seems unlikely, however, that this would
occur in the absence of cognitive symptoms.
Former player participants reporting CTE were more
likely to self-identify as black than white or other. This
may be because some comorbidities known to cause cogni-
tive problems are more prevalent in black men (eg, hyper-
tension31 and diabetes32). Additionally, because black
players are more likely to play high-impact positions,33 pre-
sumed exposure may be driving the suggestion of CTE in
clinical contexts. A recent study of symptomatic former
professional football players has noted that black players
had significantly higher indices of head injury, higher blood
pressure, higher BMI, and lower right hippocampal volume
than white participants.34 In our study, participants who
played between 5 and 9 seasons showed a higher percentage
of self-reported CTE than those who played both fewer
and more seasons. Although we cannot say for certain why
this is, it is possible that healthy worker bias may be at play
where the most injured players aren’t represented in
populations of players with longer careers.35
A limitation of our study is that the overall response
rate was relatively low (27.1%). If none of the nonpartici-
pants would have reported clinician-diagnosed CTE, then
the overall percentage of reported CTE would be only
0.76%, instead of the 2.8% among those players who par-
ticipated in our study. Thus, 0.76% should be viewed as a
lower bound of clinician-diagnosed CTE reporting in for-
mer football players. Nevertheless, it is important to note
that no player should have received a clinical diagnosis of
CTE. It is possible that cognitive status could have
affected the likelihood that a former football player joined
our study; participation among those with a disease or
more severe disease may be higher than among those with-
out because they have an interest in understanding their
condition.36 On the other hand, it is known that cognitive
impairment tends to inhibit study participation.37 Impor-
tantly, though, if that participation is not also related to
other factors (eg, linemen who report CTE participate at a
different rate than non-linemen who report CTE) then
the differences by CTE that we see in this study should
still be reflective of the whole player population. For
example, the higher prevalence of low testosterone among
former players with CTE would not be caused by former
players who report CTE participating more (or less) than
players not reporting CTE. This would only be errone-
ously caused if participation was based on both CTE
reporting and low testosterone (ie, if players who both
report CTE and have low testosterone were more likely to
participate than former players who report CTE and do
not have low testosterone). If such jointly based participa-
tion did occur, then the differences we report and their
associated p values would not reflect the true differences
in the larger population of former players, including those
who did not enroll in our study.
The use of self-report represents another limitation
of this study: medical records were not obtained, and
there was limited survey space for defining procedures, ill-
nesses, and condition severity. Furthermore, data were not
collected on clinician and medical facility types (eg, aca-
demic hospital specialists vs community providers), which
introduces additional variability into the meaning of
reported diagnoses. Because we do not know the clinical
setting and level of diagnostic workup that were used to
support the suggestion of CTE, it is challenging to under-
stand the clinical criteria used for such a diagnosis.
Comorbidity data based on self-report could even rep-
resent an under-reporting in some instances; for example,
sleep apnea, often goes unrecognized.38 Other factors, such
as number of anesthesia exposures, have been posited as
potential risks for dementia and should also be considered in
this population39 as many players often have undergone a
number of surgical procedures to address sports-related
orthopedic injuries. It must also be kept in mind that many
of the comorbidities that could increase risk of cognitive
impairment may begin early in life40,41 and may ultimately
not be consequences of exposure to professional ASF.
The data presented in this study were observational,
cross-sectional, and based on self-report and it is,
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therefore, not possible to make true inferences on the role
of comorbidities in CTE or cognitive decline for these
participants. Further research using longitudinal data,
medical records, and in-person neuropsychological testing
is necessary to better elucidate the relationships between
perceived CTE diagnoses and comorbid conditions. How-
ever, until those data become available, it is important to
draw attention to treatable conditions that may have been
overlooked or eclipsed by the suggestion of CTE.
We cannot tell whether self-reported CTE diagnoses
represent an actual diagnosis given or recorded in a medi-
cal chart, or just an articulated suspicion on the part of
the medical provider. We also cannot rule out that some
of the participants may demonstrate neuropathological
changes associated with postmortem CTE. Furthermore,
such pathology may or may not be directly linked to their
reported symptoms. Nevertheless, the possibility of incor-
rect reporting of diagnosis or just an impression left with
the player that he has CTE is of great concern. Such neb-
ulous diagnoses could produce a nocebo effect and trigger
mental health challenges, discourage further diagnostic
efforts for potentially treatable conditions, and lead to
tragic consequences. In the context of this cohort,30 the
role of nocebo-based effects on symptoms and disability42
should not be overlooked.43
Our findings emphasize the importance of careful
clinical assessment of comorbidities and other causes of
cognitive decline in former athletes with neurocognitive
symptomatology before assuming that CTE is the respon-
sible etiology. The evaluation of former contact and com-
bative sport athletes with cognitive problems should
emphasize diagnostic assessment through which treatable
conditions are prioritized and addressed, as well as a spe-
cialized and careful evaluation of all possible causes of cog-
nitive dysfunction and dementia. The results presented
here underscore the need for longitudinal studies, research
criteria for CTE phenotyping, more effective patient edu-
cation regarding clinical uncertainty in this era of intense
public discourse, and greater awareness in the public and
the medical community of relevant comorbidities.
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